Question 1

What are the most cited papers from Crolll (Germany)?

Accepted Answer

The most cited paper from Crolll (Germany) is "Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial" (Matthias P A Ebert et al., 2022), with 31 citations. Next come "An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial" (5) and "Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study" (4).

Question 2

Which research topics does Crolll (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Millimeter-Wave Propagation and Modeling, Indoor and Outdoor Localization Technologies, Human Mobility and Location-Based Analysis and Esophageal Cancer Research and Treatment.

Question 3

Which fields of science does Crolll (Germany) work in?

Accepted Answer

In all years, 46% of research at Crolll (Germany) is in Health Sciences, 23% in Physical Sciences. Its largest fields are Medicine (46%), Engineering (23%), Social Sciences (15%).